Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Anafranil 50mg capsules
0403010F0BBACAC
|
Anafranil | Clomipramine hydrochloride | Central Nervous System | No data available |
|
Antabuse 200mg tablets
0410010B0BBAAAA
|
Antabuse | Disulfiram | Central Nervous System | No data available |
|
Anzemet 200mg tablets
0406000Z0BBABAB
|
Anzemet | Dolasetron mesilate | Central Nervous System | No data available |
|
Anzemet 50mg tablets
0406000Z0BBAAAA
|
Anzemet | Dolasetron mesilate | Central Nervous System | No data available |
|
Anzemet IV 100mg/5ml solution for injection ampoules
0406000Z0BBADAD
|
Anzemet | Dolasetron mesilate | Central Nervous System | No data available |
|
Anzemet IV 12.5mg/0.625ml solution for injection ampoules
0406000Z0BBACAC
|
Anzemet | Dolasetron mesilate | Central Nervous System | No data available |
|
Apclaven XL 150mg capsules
0403040W0CGACAE
|
Apclaven XL | Venlafaxine | Central Nervous System | No data available |
|
Apclaven XL 37.5mg capsules
0403040W0CGAAAS
|
Apclaven XL | Venlafaxine | Central Nervous System | No data available |
|
Apclaven XL 75mg capsules
0403040W0CGABAD
|
Apclaven XL | Venlafaxine | Central Nervous System | No data available |
|
APO-go 20mg/2ml solution for injection ampoules
0409010A0BCABAS
|
APO-go | Apomorphine hydrochloride | Central Nervous System | No data available |
|
Apodespan PR 50mg/200mg tablets
0409010N0BGAAAE
|
Apodespan | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | No data available |
|
Apomorphine 100mg/20ml inf pre-filled syringes
0409010A0AABABA
|
Apomorph hydrochloride (Parkinsonism) | Apomorphine hydrochloride | Central Nervous System | No data available |
|
Apomorphine 20mg/2ml solution for injection ampoules
0409010A0AAASAS
|
Apomorph hydrochloride (Parkinsonism) | Apomorphine hydrochloride | Central Nervous System | No data available |
|
Apomorphine 2mg/2ml solution for injection ampoules
0409010A0AAAIAI
|
Apomorph hydrochloride (Parkinsonism) | Apomorphine hydrochloride | Central Nervous System | No data available |
|
Apomorphine 50mg/5ml solution for injection ampoules
0409010A0AAAVAV
|
Apomorph hydrochloride (Parkinsonism) | Apomorphine hydrochloride | Central Nervous System | No data available |
|
Aprepitant 30mg/5ml oral suspension
0406000ADAAAFAF
|
Aprepitant | Aprepitant | Central Nervous System | No data available |
|
Aprepitant 40mg/5ml oral suspension
0406000ADAAADAD
|
Aprepitant | Aprepitant | Central Nervous System | No data available |
|
Arbil MR 200mg tablets
0408010C0BGAAAG
|
Arbil | Carbamazepine | Central Nervous System | No data available |
|
Arbil MR 400mg tablets
0408010C0BGABAH
|
Arbil | Carbamazepine | Central Nervous System | No data available |
|
Aripiprazole 300mg inj vials
0402020ADAAAEAE
|
Aripiprazole | Aripiprazole | Central Nervous System | No data available |
|
Aripiprazole 7.5mg/ml oral solution
0402010ADAAAJAJ
|
Aripiprazole | Aripiprazole | Central Nervous System | No data available |
|
Aripiprazole 960mg/3.2ml prolonged-release inj pf syringes
0402020ADAAACAC
|
Aripiprazole | Aripiprazole | Central Nervous System | No data available |
|
Arkolamyl 10mg orodispersible tablets
040201060BDAAAT
|
Arkolamyl | Olanzapine | Central Nervous System | No data available |
|
Arkolamyl 15mg orodispersible tablets
040201060BDABAU
|
Arkolamyl | Olanzapine | Central Nervous System | No data available |
|
Arkolamyl 20mg orodispersible tablets
040201060BDADAV
|
Arkolamyl | Olanzapine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.